Purdue Pharma proposes $12B settlement to clean up opioid mess — report
After months of negotiations with states and federal plaintiffs accusing it of instigating the opioid crisis through aggressive and deceptive marketing tactics, Purdue Pharma is ready to pay $10 to $12 billion to settle it all.
The potential deal would cover hundreds of lawsuits being waged against the company by states, cities, towns and tribes, which is being overseen by United States district judge Dan Polster in Cleveland, alongside cases involving other prescription opioid makers. As part of the deal, the Sackler family — who had been charged with building a “multibillion-dollar drug empire based on addiction” — will give up ownership in Purdue.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.